Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 16, 2013
Scared witless about death--ovarian cancer narratives comparedIsabella A J van Duin, Ad A KapteinEuropean Journal of Cancer (Oxford, England : 1990)|September 12, 2022
Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic reviewLaurens S Ter Maat, Isabella A J van Duin, Sjoerd G Elias, et al.European Journal of Cancer (Oxford, England : 1990)|July 11, 2024
Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanomaIsabella A J van Duin, Mark Schuiveling, Laurens S Ter Maat, et al.European Journal of Cancer (Oxford, England : 1990)|May 28, 2026
AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with responseMark Schuiveling, Isabella A J van Duin, Laurens S Ter Maat, et al.JAMA Oncology|October 16, 2025
Artificial Intelligence-Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti-PD-1-Based Treated MelanomaMark Schuiveling, Isabella A J van Duin, Laurens S Ter Maat, et al.European Journal of Cancer (Oxford, England : 1990)|March 30, 2023
CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanomaLaurens S Ter Maat, Isabella A J van Duin, Sjoerd G Elias, et al.Journal of the National Cancer Institute|February 21, 2025
Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort studyMark Schuiveling, Laurens S Ter Maat, Isabella A J Van Duin, et al.Scientific Reports|December 31, 2024
Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanomaLaurens S Ter Maat, Rob A J De Mooij, Isabella A J Van Duin, et al.International Journal of Cancer|February 27, 2023
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanomaIsabella A J van Duin, Sjoerd G Elias, Alfonsus J M van den Eertwegh, et al.International Journal of Cancer|January 31, 2024
A prediction model for response to immune checkpoint inhibition in advanced melanomaIsabella A J van Duin, Rik J Verheijden, Paul J van Diest, et al.Pageof 1